TY - JOUR
T1 - A portable multiplex vertical flow immunoassay platform for Tier 1 biothreat detection in biofluids and environmental matrices
AU - Devadhasan, Jasmine Pramila
AU - Summers, Alexander Jarrett
AU - Gu, Jian
AU - Helton, James
AU - Thomas, Baiju
AU - Berner, Vanessa
AU - Gates-Hollingsworth, Marcellene
AU - Atta, Supriya
AU - Vo-Dinh, Tuan
AU - Montgomery, Douglas C.
AU - AuCoin, David
AU - Zenhausern, Frederic
N1 - Publisher Copyright:
© 2026 Elsevier B.V.
PY - 2026/3/15
Y1 - 2026/3/15
N2 - Rapid, field-deployable diagnostics are critical for detecting high-priority biothreats, yet most platforms lack sensitivity, multiplexing, or usability in resource-limited settings. We present VeriFAST, a compact vertical flow immunoassay (VFI) system integrating automated fluid handling, a nitrocellulose-based multiplex membrane, and smartphone-enabled image processing for real-time analysis. Using a gold nanoparticle sandwich format, VeriFAST simultaneously detects four Tier 1 bacterial antigens LcrV and F1 (Yersinia pestis), FtLPS (Francisella tularensis), CPS (Burkholderia pseudomallei). The system achieved limits of detection of 0.05 ng/mL for F1, 0.0125 ng/mL for CPS and 0.625 ng/mL for LcrV in serum, urine, and soil extracts, with total assay time under 30 min. Reagent stability testing showed that buffers and detection antibodies retained full function for 12 months under ambient or refrigerated storage, whereas capture antibodies began to show signal drift after 3 months at room temperature, even with desiccant protection. Matrix-specific optimization further enabled high reproducibility and low background across complex samples. By combining multiplexing, automated processing, and mobile analytics in a portable format, VeriFAST addresses critical gaps in field diagnostics and offers a scalable solution for biothreat detection in public health, military, and environmental response.
AB - Rapid, field-deployable diagnostics are critical for detecting high-priority biothreats, yet most platforms lack sensitivity, multiplexing, or usability in resource-limited settings. We present VeriFAST, a compact vertical flow immunoassay (VFI) system integrating automated fluid handling, a nitrocellulose-based multiplex membrane, and smartphone-enabled image processing for real-time analysis. Using a gold nanoparticle sandwich format, VeriFAST simultaneously detects four Tier 1 bacterial antigens LcrV and F1 (Yersinia pestis), FtLPS (Francisella tularensis), CPS (Burkholderia pseudomallei). The system achieved limits of detection of 0.05 ng/mL for F1, 0.0125 ng/mL for CPS and 0.625 ng/mL for LcrV in serum, urine, and soil extracts, with total assay time under 30 min. Reagent stability testing showed that buffers and detection antibodies retained full function for 12 months under ambient or refrigerated storage, whereas capture antibodies began to show signal drift after 3 months at room temperature, even with desiccant protection. Matrix-specific optimization further enabled high reproducibility and low background across complex samples. By combining multiplexing, automated processing, and mobile analytics in a portable format, VeriFAST addresses critical gaps in field diagnostics and offers a scalable solution for biothreat detection in public health, military, and environmental response.
KW - Environmental biosensing
KW - Mobile app
KW - Multiplex detection
KW - POC diagnostics
KW - VeriFAST system
KW - Vertical flow immunoassay
UR - https://www.scopus.com/pages/publications/105026440265
UR - https://www.scopus.com/pages/publications/105026440265#tab=citedBy
U2 - 10.1016/j.bios.2025.118352
DO - 10.1016/j.bios.2025.118352
M3 - Article
C2 - 41485248
AN - SCOPUS:105026440265
SN - 0956-5663
VL - 296
JO - Biosensors and Bioelectronics
JF - Biosensors and Bioelectronics
M1 - 118352
ER -